Athira pharma provides 2023 pipeline outlook

Advancing small molecule therapeutic candidates with clinical and preclinical data suggesting potential neuroprotective, neurotrophic, procognitive and disease-modifying effects

ATHA Ratings Summary

ATHA Quant Ranking